title: Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: M M
authors.initials: MM
authors.lastname: Redfield
authors.forename: W J
authors.initials: WJ
authors.lastname: Nicholson
authors.forename: W D
authors.initials: WD
authors.lastname: Edwards
authors.forename: A J
authors.initials: AJ
authors.lastname: Tajik
mesh_terms: D000328:Adult; D004452:Echocardiography; D004876:Ergot Alkaloids / Q000009:adverse effects*; D004878:Ergotamine / Q000009:adverse effects; D005260:Female; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008784:Methysergide / Q000009:adverse effects; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000139:chemically induced; D008946:Mitral Valve Stenosis / Q000139:chemically induced
chemical_list: D004876:Ergot Alkaloids; D004878:Ergotamine; D008784:Methysergide